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Abstract
Background: Recently, the presence of an unauthorized genetically modified (GM) Bacillus subtilis bacterium
overproducing vitamin B2 in a feed additive was notified by the Rapid Alert System for Food and Feed (RASFF). This
has demonstrated that a contamination by a GM micro-organism (GMM) may occur in feed additives and has
confronted for the first time,the enforcement laboratories with this type of RASFF. As no sequence information of
this GMM nor any specific detection or identification method was available, Next GenerationSequencing (NGS) was
used to generate sequence information. However, NGS data analysis often requires appropriate tools, involving
bioinformatics expertise which is not alwayspresent in the average enforcement laboratory. This hampers the use of
this technology to rapidly obtain critical sequence information in order to be able to develop a specific
qPCRdetection method.
Methods: Data generated by NGS were exploited using a simple BLAST approach. A TaqMan® qPCR method was
developed and tested on isolated bacterial strains and on the feed additive directly.
Results: In this study, a very simple strategy based on the common BLAST tools that can be used by any
enforcement lab without profound bioinformatics expertise, was successfully used toanalyse the B. subtilis data
generated by NGS. The results were used to design and assess a new TaqMan® qPCR method, specifically detecting
this GM vitamin B2 overproducing bacterium. The method complies with EU critical performance parameters for
specificity, sensitivity, PCR efficiency and repeatability. The VitB2-UGM method also could detect the B. subtilis strain
in genomic DNA extracted from the feed additive, without prior culturing step.
Conclusions: The proposed method, provides a crucial tool for specifically and rapidly identifying this unauthorized
GM bacterium in food and feed additives by enforcement laboratories. Moreover, this work can be seen as a case
study to substantiate how the use of NGS data can offer an added value to easily gain access to sequence
information needed to develop qPCR methods to detect unknown andunauthorized GMO in food and feed.
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Background
Riboflavin (vitamin B2) is necessary for basic cell metab-
olism but is not synthetized by higher animals and needs
to be ingested. Therefore, the vitamin is commercialized
for nutritional use in the fortification of various food
and feed products. It is also commonly used as a color-
ant in food such as ice cream, cheeses, mayonnaises and
sauces, and as a medical identification aid, because of its
intense yellow color [1–3].
At the present time, fermentation using microbio-
logical processes is widely applied to commercially pro-
duce riboflavin [4, 5] and genetically modified (GM)
Bacillus (B.) subtilis overproducing riboflavin is one of
the main organism currently used for riboflavin’s indus-
trial production [2, 4, 6–8]. One common genetic
method used to enhance riboflavin production derived
from fermentation by GM B. subtilis, is to clone the
riboflavin biosynthesis operon (ribG, ribB, ribA and
ribH) from B. subtilis under the control of a strong con-
stitutive promoter into (integrative) plasmids (e.g.
pUC19, pBR322) [9–11].
In the framework of EU legislation [12, 13], companies
wanting to market in the EU a specific additive pro-
duced by Genetically Modified Microorganisms
(GMMs), like vitamin B2, need to submit an application
that will be evaluated by the European Food Safety Au-
thority (EFSA). This will result in a scientific opinion
concerning the safety and the efficacy of the product
EFSA [14]. According to the EFSA guidance, food and
feed additives produced by GMMs intended for human
and animal consumption must be pure. This means that
both GMMs (either alive or killed) and newly introduced
genes should have been removed from the final product
[14]. This is especially important for safety evaluation as
the amount of recombinant residual host cell DNA as
well as the risk of gene transfer need to be assessed.
Based on this information, EFSA will be able to deliver
its scientific opinion concerning the product, includ-
ing whether or not the production strain or its re-
combinant DNA was detected in the final product
(for example see [15]).
According to EU legislation [16, 17], labelling is not re-
quired for vitamins and additives produced by a GMM be-
cause the producer strain (either alive or killed) and its
components, including DNA, are no longer present in the
commercialized product as the final product should be
carefully purified, not containing any residual GMM mater-
ial. Therefore, unlike for plant GMOs, the companies do
not have to provide an event-specific method to trace the
GMO in food and feed products on the EU market and
there is no control by enforcement laboratories, for the cor-
rectness of the labelling. It is assumed that the company
bringing the GMM-derived riboflavin to the market has
verified the absence of the GMM or its recombinant DNA
in the final product, so that only “pure” product can be
found on the EU market. However, very recently, it was
demonstrated that GMM-contamination in feed additives
could occur as a viable GM -B. subtilis was found in an
imported lot of vitamin B2 feed additive placed on the EU
market. This has led in September 2014 to a notification
for unauthorized GMO (UGM) in the European Rapid
Alert System for Food and Feed (RASFF 2014–1249 [18]).
Confronted with this RASFF, as no official method is
available for detecting this GMM in food and feed, two
methods previously developed for other purposes have
been proposed and used by enforcement laboratories con-
trolling the GMO-content in food and feed at the EU mar-
ket. The first one allows identifying the presence of B.
subtilis strains and includes a PCR amplification of the 16S
rRNA gene followed by its sequencing [19]. This method is
not especially convenient and is more laborious. Indeed, it
requires sequencing in addition to the PCR analysis and
this is not commonly used by the routine laboratories in
GMO analysis. The second method allows detecting the
presence of recombinant DNA. It is a real-time PCR
method that was used as an internal amplification control
targeting the plasmid pUC19, commonly used to construct
genetically modified B. subtilis. This method was originally
developed in duplex with a qPCR method for the detection
of pathogenic Yersinia enterocolitica in food samples [20].
It targets a standard vector construct (i.e. pUC19), and con-
sequently has a large spectrum of targets commonly used
in many GMM constructs. Moreover, traces of such kind of
recombinant DNA could be found in mixes containing op-
timized Taq polymerase enzyme used for PCR. Therefore,
these 2 methods both provide ambiguous results in the de-
tection of GM-B. subtilis overproducing riboflavin. There is
a need to develop a faster, specific method targeting this
particular GM-strain to be put at the disposition of the en-
forcement laboratories.
In order to develop such a specific method, the GM-B.
subtilis overproducing riboflavin was isolated from three
different samples of imported vitamin B2 feed additive
and collected by the French competent authorities in the
framework of the RASFF 2014–1249. Next generation
sequencing (NGS) was performed on the genomic DNA
extracted from one of the isolates. The sequencing reads
were de novo assembled and genome annotation was
performed on the contig sequences [21]. However, NGS
data analysis often requires appropriate tools, involving
bioinformatics expertise which is not always present in
the average enforcement laboratory. This hampers the
use of this technology to easily obtain critical sequence
information in order to be able to develop a specific
qPCR detection method.
In this study, the DNA sequences previously generated
by the NGS approach [21] were used to develop a Taq-
Man® qPCR method targeting the junction between the
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B. subtilis riboflavin operon and the vector used to con-
struct this GM-strain. Different performance criteria of
the developed qPCR method such as specificity, sensitiv-
ity, PCR efficiency and repeatability were evaluated ac-
cording to the GMO guidelines [22, 23]. Finally, the
qPCR method was assessed directly on the gDNA ex-
tracts from the three different samples of imported vita-
min B2 feed additive and collected by the French
competent authorities. The method proposed in the
present study provides a crucial tool for identifying spe-
cifically and rapidly the GM-B. subtilis overproducing
riboflavin firstly detected in the imported vitamin B2
feed additive. Moreover, it illustrates that NGS data can
be used very easily, without specific bioinformatics ex-
pertise, in order to obtain crucial information to develop
specific TaqMan® qPCR methods, to detect unknown
and unauthorized GMO in food and feed.
Results and Discussion
Sequence analysis to identify the junction and design of
the GM-specific qPCR assay
The first step in the development of the specific qPCR
assay consisted of identifying the junction of the GM-
insert into the Bacillus subtilis GM-strains extracted from
vitamin B2 samples 2014–3557 [Genbank: JYFL01000000]
[21]. As elaborated in Methods, a BLAST study of the
contigs of the previously published sequence of the GM-
Bacillus subtilis 2014–3557 isolated from vitamin B2 80 %
[Genbank:JYFL01000000.1] [21] was used to identify the
contigs containing the riboflavin biosynthesis operon
ribGBAH, with a focus on locating the ribA gene as it has
been previously reported that additional expression of this
gene encoding the rate limiting enzyme in riboflavin syn-
thesis increases riboflavin synthesis even more as com-
pared to only overexpression of ribGBAH [7, 11, 24]. The
overlapping contigs Contig0022 [Genbank:-
JYFL01000022.1] and Contig0016 [Genbank:-
JYFL01000016.1] were retrieved as containing genes
having 100 % similarity with B. subtilis subsp. subtilis str.
168 genes ribH, ribBA, ribE and ribD, involved in ribofla-
vin biosynthesis [7, 25], as it could also be deduced from
the annotation of the GM-B. subtilis genome sequence
[Genbank:JYFL01000000] [21] (Fig. 1). Using the publicly
available genome sequence of B. subtilis subsp. subtilis str.
168 [Genbank:CP010052.1] and a BLAST analysis, Con-
tig00019 was identified as the other contig adjacent to
Contig00022 (Fig. 1). However, a gap of 37 basepairs be-
tween Contig00019 and Contig00022 was observed when
comparing these contig sequences to the B. subtilis subsp.
subtilis str. 168 genome sequence [Genbank:CP010052.1]
. PCR and sequence analysis was used to confirm that the
genomic regions present on both contigs are indeed
Fig. 1 Amplicon, primers and probe sequences of the VitB2-UGM qPCR assay, position of the junction GM-plasmid-insert. Green: similarity with plasmid
pSM19035 and pBT233, light blue: “insert” – similarity with Bacillus subtilis subsp. subtilis str. 168 sequences (including riboflavin biosynthesis genes – in
bold); striped blue box: gap of 37 basepairs between Contig00019 and Contig00022, sequence obtained by PCR followed by sequencing; Underlined:
primers of the VitB2-UGM qPCR assay, bold: probe of the VitB2-UGM qPCR assay; the size and orientation of the contigs has been indicated at the top,
as also the position of the junctions in the respective contigs; Genes located on the respective contigs are indicated with green and light blue arrows
using annotation of B. subtilis strain 2014–3557, [Genbank: JYFL01000000] – genes encoding following proteins: bin3 - putative transposon Tn552
DNA-invertase; hyp – hypothetical protein; repS - protein RepS; copR - plasmid copy control protein CopR; KIX80113.1: accumulation-associated protein;
hyp - hypothetical protein; tcpC - conjugative transposon protein TcpC; ypuI_2 - part of putative protein YpuI_2; scpB - segregation and condensation
protein B; scpA-1 - segregation and condensation protein A; ypuF - putative protein YpuF; ribT_1 - protein RibT; ribH_1 - 6,7-dimethyl-8-ribityllumazine
synthase; ribBA_1 = GTP cyclohydrolase-2; ribE_1 - riboflavin synthase; ribD_1–5-amino-6-(5-phosphoribosylamino)uracil reductase; ypuD - putative
protein YpuD; sipS - signal peptidase I S; ypzJ - putative protein YpzJ; hyp - hypothetical protein; ypuB - putative protein YpuB; ypzD - spore germination
protein-like protein YpzD; hyp - hypothetical protein; hyp - hypothetical protein; KIX80145.1 - N-acetylmuramoyl-L-alanine amidase domain-containing
protein; hyp - hypothetical protein; hyp – hypothetical protein
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adjacent in the GM-Bacillus genome (see Additional file
1: Figure S1 and Additional file 2: Figure S2). Further in-
vestigation of Contig00019 and Contig00016 revealed the
presence of a region with 100 % similarity to the
pSM19035 [Genbank:AY357120.1] or pBT233 [Gen-
bank:NG_034603.1] plasmid (Fig. 1). It needs to be further
investigated whether these plasmid sequences are inte-
grated in the GM-Bacillus genome. Nevertheless, this vec-
tor has probably been used to construct the GM-strain.
Therefore, the junctions between the non-naturally
present vector sequences and the Bacillus region contain-
ing the riboflavin biosynthesis genes (GM-cassette) were
to be targeted by the event-specific TaqMan® qPCR assay.
The GM-cassette junctions were found around position
1454 in the contig0019 and around position 5887 in the
contig0016 (Fig. 1). Primer pairs and probes have been de-
signed at these positions and tested on the GM-Bacillus
subtilis 2014–3557 (data not shown). One of the assays tar-
geting the junction on the Contig0019 was kept for further
evaluation (Table 1 and Fig. 1). This assay, called the VitB2-
UGM qPCR assay, was then evaluated for its specificity.
Determination of VitB2-UGM qPCR assay’s specificity
The specificity test allows testing the inclusivity and
exclusivity of the VitB2-UGM qPCR assay. The ex-
perimental design involved 3 Bacillus subtilis GM-
strains overproducing riboflavin that were extracted
from three samples of imported vitamin B2 80 %, 51
non-target strains representing 28 species belonging
to 19 genera, a CTD (DNA diluent) and an NTC
(Table 2). The non-target microorganisms to test the
exclusivity were chosen among taxonomically closely
related (e.g. other Bacillus species) and not closely re-
lated (pathogenic or not) bacteria that can be present
in the environment and in food and feed matrices
[26]. In feed/food additives, normally there should not
be any bacteria present, as elaborated above. However,
some species also known to be used as GMM were
included in the specificity test (e.g. E. coli, B. licheni-
formis). The VitB2-UGM qPCR assay amplified 100 %
(3/3) of the tested GM-B. subtilis strains overprodu-
cing riboflavin and none (0/51) of the non-target
samples nor the No Template Control (NTC) nor the
diluent DNA (CTD) (Table 2). Thus, the detection of
the GM-Bacillus subtilis 2014–3557 using the VitB2-
UGM qPCR assay is 100 % specific for the GM-
strain. This was somehow expected as the VitB2
UGM qPCR assay is a construct specific assay (de-
signed on the junction between the between inserted
endogenous riboflavin biosynthesis genes (“GM-cas-
sette”) and non-naturally present sequences. The pres-
ence of this junction is not expected in wild-type
bacteria, no matter what their origin or phylogenetic
relationship is. The sequence of the amplicon was de-
termined and corresponded to the expected one (data
not shown).
Determination of VitB2-UGM qPCR assay’s dynamic range
and PCR efficiency
The dynamic range of a qPCR assay is the range of
concentrations where the assay performs linearly. This
was assessed for the VitB2-UGM qPCR assay by the
analysis in duplicate of a serial dilution of gDNA
(10,000 to 0.01 theoretical genomic copies) of the
GM-Bacillus subtilis strain 2014–3557 overproducing
riboflavin [21]. In addition, this analysis allowed for
the assessment of the coefficient of determination
(R2) and the PCR efficiency (E). The coefficient of de-
termination (R2) is an indicator of how well the data
fit the linear regression curve. The VitB2-UGM qPCR
assay performed linearly between 1 and 10,000 gen-
omic copies as its R2-value, i.e. 0.99, exceeds the re-
quired 0.98 [22, 23] (Fig. 2). From the dynamic range
analysis, the PCR efficiency (E) was calculated. The
VitB2-UGM qPCR assay displayed a PCR efficiency of
105.4 %, thereby corresponding to the accepted limits
fixed for qPCR qualitative method used to detect
GMO of 80–120 % as well as to the ones used to
quantify GMO of 90–110 % [22, 23].
Determination of VitB2-UGM qPCR assay sensitivity and
repeatability
The sensitivity test was performed to determine the
LOD of the VitB2-UGM qPCR assay. The LOD is de-
fined as the lowest concentration of an analyte giving a
positive result with a probability of 95 % [22, 23]. The
LOD of the VitB2-UGM qPCR assay was determined to
be between 1 and 2 copies (Table 3) complying with the
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requirement “below 25 genomic copies” [23, 27]. The r-
values of the Cq-values ranged between 1.3 to 3.2 Cq.
The RSDr-values of the Cq-values were between 1.4 to
3.3 % (Table 3). There is no limit fixed for these criteria
for qualitative qPCR methods [27].
Test of the VitB2-UGM qPCR assay on vitamin B2 80 %
feed additive samples
To verify if the developed VitB2-UGM qPCR assay
targeting the GM-Bacillus subtilis 2014–3557 overpro-
ducing riboflavin is able to detect this GM strain in real-
Table 2 Selectivity assessment of the VitB2-UGM qPCR assay for detection of the GM-Bacillus subtilis 2014–3557 overproducing
riboflavin
Bacterial species Origin Reference Cq
Bacillus subtillis GM (2014–3557) SCL 2014–3557 22.28
Bacillus subtillis GM (2014–3558) SCL 2014–3558 26.10
Bacillus subtillis GM (2014–3559) SCL 2014–3559 25.08
Bacillus subtillis subtilis (24 isolates) UCL a N/A
Bacillus cereus IPH-FP ATCC 14579 N/A
Bacillus lentus IPH-FP TIAC 0101 N/A
Bacillus licheniformis IPH-FP TIAC 0102 N/A
Bacillus sphaericus IPH-FP TIAC 0104 N/A
Bacillus thuringiensis IPH-FP TIAC 0096 N/A
Bacillus mycoides IPH-FP TIAC 0097 N/A
Bacillus circulans IPH-FP TIAC 0100 N/A
Escherichia coli IPH-FP ATCC 25922 N/A
Shigella boydii 10 Salm -NRC 12–2582 N/A
Aeromonas hydrophila IPH-QML 6688 (M/2862)EEQ 2003/2 N/A
E. coli O145:H28 IPH-FP TIAC 1360 N/A
Campylobacter jejuni IPH-FP ATCC 33291 N/A
Citrobacter freundii IPH-FP TIAC 0554 N/A
Enterobacter aerogenes IPH-QML 3778 (M/317-M/3785) EEQ 2002/3 N/A
Streptococcus pyrogenes IPH-QML ATCC 19615 N/A
Hafnia alvei IPH-QML 7186 N/A
Klebsiella pneumoniae IPH-FP TIAC 0446 N/A
Listeria monocytogenes List- NRC ATCC 51772 N/A
Proteus mirabilis IPH-FP TIAC 0726 N/A
Providencia rettgeri IPH-QML 1521 (M/831) EEQ 1999/2 N/A
Pseudomonas aeruginosa IPH-FP LMG 6395 N/A
Salmonella enterica enterica Enteritidis Salm-NRC H,VI,6,32 N/A
Salmonella enterica enterica Typhimurium Salm-NRC H,II,13,13 N/A
Serratia marcescens IPH-QML 7015 N/A
Staphylococcus aureus IPH-FP ATCC 25923 N/A
Vibrio parahaemolyticus IPH-FP TIAC 0610 N/A
Yersinia enterocolitica IPH-FP LMG 15558 N/A
NTC N/A
CTD N/A
Cq: Cq value obtained with the VitB2-UGM qPCR assay under the conditions described in Methods; N/A: no amplification; a: reference numbers of B. subtilis strains
used: W04-S10, E07-S05, E08-S06, W05-S03, W10-S01, E11-S02, E12-S04, E14-S06, E16-S07, W13-S04, E23-S03, W16-S03, E28-S04, E33-S01, E34-S01, E38-S02,
W24-S03, SI0005, SI0212, SUB033, SUB043, SUB056, BNBs4, BNBs6; SCL: Service Commun des Laboratoires, Illkirch-Graffenstaden, France; UCL: Food and
Environmental Microbiology, Earth and Life Institute, Faculty of Bioscience Engineering, Université Catholique de Louvain, Louvain-la-Neuve, Belgium; IPH-FP:
Foodborne pathogens service, Scientific Institute of Public Health, Brussels, Belgium; Salm-NRC: Belgian Salmonella and Shigella National Reference Center,
Scientific Institute of Public Health, Brussels, Belgium; IPH-QML: Quality of Medical Laboratories, Scientific Institute of Public Health, Brussels, Belgium; List-NRC:
Belgian Listeria National Reference Center, Scientific Institute of Public Health, Brussels, Belgium
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life samples, the developed qPCR assay has been tested
on gDNA extracts from the three samples of imported
vitamin B2 80 % feed additive and containing these GM-
Bacillus strains.
The DNA extracted from each of the samples gave a
clear signal when using the VitB2-UGM qPCR assay at a
Cq-value around 14 for 10 times dilutions and around
17.5 for 100 times dilutions (Table 4).
This demonstrates that the VitB2-UGM qPCR assay
can be used to detect the GM-Bacillus strain in real-life
samples.
Conclusions
As no method was available to specifically detect the
presence of an unauthorized GMO consisting of a GM
Bacillus subtilis bacterium overproducing vitamin B2
found in a feed additive (RASFF 2014–1249), in the
present study a new TaqMan® qPCR method specifically
detecting this GM vitamin B2 overproducing bacterium
was designed. To be able to develop the VitB2-UGM
qPCR assay, critical sequence information was retrieved
and used from massive sequence data previously ob-
tained by an NGS approach [21]. To analyse these data,
a very simple strategy based on the common BLAST
tools, that can be used by any enforcement lab without
profound bioinformatics expertise, was successfully
followed. This allowed to design a specific qPCR method
targeting the junction between inserted endogenous
riboflavin biosynthesis genes (“GM-cassette”) and non-
naturally present sequences (vector).
To guarantee the high-standard quality of the VitB2-
UGM method, acceptance parameters like specificity, sen-
sitivity, PCR efficiency and repeatability commonly used
to validate a qualitative qPCR method for the detection of
GMO were evaluated [22, 23, 27]. The method complies
with the acceptance criteria for all of the assessed parame-
ters. In addition, to further assess the applicability of the
newly developed method not only for isolated strains but
also for feed products, the VitB2-UGM method was suc-
cessfully tested on gDNA immediately extracted from the
feed additive from where the GM-strains were isolated.
This confirms its effective use in routine analysis for reli-
able detection by enforcement laboratories of the GM- B.
subtilis bacterium overproducing vitamin B2 (RASFF
2014–1249). In the future, this specific method can be
used to screen feed and food products regarding this spe-
cific GM-bacterium overproducing vitamin B2. However,
this method might have a broader application, as vitamin
B2 is used in a wide range of products present at both the
food and feed market [1]. Moreover, this vitamin is not a
unique example of additive produced by GMM. Indeed,
GMM are used to produce other vitamins, additives and
processing agents for the food industry [1]. Companies are
responsible for ensuring that their food and feed put at
the market are safe, pure, and that it complies with legisla-
tion on food and feed additives and regulation on redu-
cing or eliminating human health risks caused by possible
contaminants. However, in view of the RASFF demon-
strating the presence of an unauthorized GM (UGM) con-
taminant in feed, the intensive use of GMM to synthetize
food and feed additives, as well the possible import of
these products in EU, the question is raised if a more sys-
tematic survey of the EU market for GMM food and feed
contaminants in additives is not necessary.
Hereto, our study underlines that when this NGS
strategy is applied on unknown and unauthorized
GMM, it delivers a massive amount of information that
Fig. 2 Dynamic range, coefficient of determination (R2) and PCR
efficiency (E) of the developed VitB2-UGM qPCR assay. Data were
obtained from two replicates at each concentration expressed in
estimated copy number of genome
Table 3 Limit of detection determination and repeatability of Cq-values of the VitB2-UGM qPCR assay
Estimated copy number Mean Cq values ± SD Positive signals (%) RSDr r
10 31.99 ± 0.73 100 2.3 2
5 33.01 ± 0.47 100 1.4 1.3
2 34.86 ± 1.15 100 3.3 3.2
1 35.71 ± 1.07 94.4 na na
0.1 36.41 ± 0.09 22.2 na na
DBC (negative control) N/A 0 na na
Average, standard deviation and percentage of positive signal of Cq-values and statistical analysis of the Cq values obtained at each dilution point (Total repeats
n=18). N/A: no amplification; na: not applicable. DBC: dilution buffer control
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can be easily used by enforcement laboratories without
specific bioinformatics expertise for the development of




The bacterial strains used in this study are listed in
Table 2. A panel of DNA extracted from 51 bacterial
strains (24 Bacillus subtilis strains, 7 others species of
the Bacillus genus (B.) and 20 strains from 18 other bac-
terial genera, all obtained from National Reference
Centres and Laboratories and C. Nannan from UCL,
Belgium) and 3 GM-B. subtilis strains has been tested.
The 3 GM-B. subtilis strains (2014–3557, 2014–3558
and 2014–3559) were isolated from three samples of
imported vitamin B2 80 % feed additive powder and
analysed by the French GMO-Laboratory “Service
commun des Laboratoires” in the framework of the
RASFF 2014–1249. No ethical approval was required
for this study as no humans, human data or animals
were involved.
Bacterial growth conditions, DNA extraction
quantification and sequencing
For the specificity test, DNA of the Bacillus strains (in-
cluding the GM ones) was extracted by boiling as previ-
ously described [28]. For the other strains, DNA was
extracted using the “Gram-Negative or Gram-Positive
Bacteria” protocol of the DNeasy Blood and Tissue Kit
(Qiagen Benelux–B.V., KJ Venlo, the Netherlands) from
the pellet of 2 ml of overnight cultures of each bacterial
strain grown in Brain-Heart Infusion (BHI) broth at the
adequate temperature and oxygen condition. For the sen-
sitivity test, the DNA from the GM-B. subtilis 2014–3557
strain was extracted from the pellet of 84 ml of overnight
culture under the conditions specified above, using the
Genomic-tip 100/G (Qiagen, Benelux–B.V., KJ Venlo, the
Netherlands). All kits were used according to the manu-
facturer’s recommendations. The DNA concentration was
determined using a Nanodrop® 2000 device. The DNA
quality was verified via the A260/A280 and A260/A230
ratio and on agarose gel (1 %). Sequencing was performed
on a ABI3130xl Genetic Analyzer (Life Technologies,
Gent, Belgium) following the manufacturer’s instructions.
Sequence analysis to identify the contig containing the
junction
To identify which contig of the GM-B. subtilis 2014–3557
genome sequence [Genbank:JYFL00000000] [21]) contains
the natural riboflavin biosynthesis genes (“GM-cassette”),
a megablast of each of the 36 contigs was performed.
Contigs matching with riboflavin biosynthesis genes were
further analysed by megablast to determine the position of
the junction between inserted natural riboflavin biosyn-
thesis genes (“GM-cassette”) and the non-naturally
present sequence (vector). These sequences were then
used to develop the GM-B. subtilis 2014–3557 overprodu-
cing riboflavin-specific qPCR assay.
PCR analysis to confirm the order of the contigs
Contig00019 and Contig00016
The PCR was performed in a final reaction volume of 25
μl containing 1× DreamTaq Green Master Mix (Thermo
Fisher Scientific), 400 nM of forward (Scaf-19-F3-seq, 5′
TTTCGGTACTCAATCAGCTTTTC 3′) and reverse pri-
mer (Scaf-22-R-seq, 5′ CAAGGTGCTTCCTCCTTTAAT
3′), and 5 μl DNA template (corresponding to 106 gen-
omic copies of the GM-B. subtilis 2014–3557 strain ex-
tracted with the Genomic-tip 100/G kit (Qiagen Benelux
– B.V., KJ Venlo, the Netherlands). The following protocol
was used in a thermal cycler: 2 min at 95 °C, 35 cycles of
30 s at 95 °C, 30 s at 55 °C and 1 min at 72 °C, 10 min at
72 °C. The PCR product (600 bp) was visualized by agar-
ose gel electrophoresis (1 % agar) with ethidium bromide
staining. The PCR product was subsequently purified with
the Wizard PCR clean-up kit (Promega Benelux B.V.,
Leiden, the Netherlands). This DNA was used for bidirec-
tional Sanger sequencing (on a ABI3130XL Genetic
Analyzer instrument, according to the manufacturer’s
instructions), using the primers Scaf-19-F3-seq and Scaf-
22-R-seq. The obtained sequences were aligned to the cor-
responding one of the B. subtilis subsp. subtilis str. 168
genome sequence [Genbank:CP010052.1] using DNAS-
TAR Lasergene software.
Development and in silico assessment of primer pairs
The qPCR assay developed makes use of an hydrolysis
probe, also known as TaqMan® probe. The design of the
primers and probe for the TaqMan® qPCR assay to de-
tect the GM-junction was done using the “Primer 3”
program [29, 30] with the “product size range” param-
eter set at “60 to 120 bp” and “primer size” optimal set
at “22 bases” and a part of the DNA sequence of contig-
Table 4 Test of VitB2-UGM qPCR assay on Vitamin B2 80 %
samples
Sample Dilution Average Cq-value
Sample vitamin B2 80 % (2014–3557) 1/10 13.9
1/100 17.4
Sample vitamin B2 80 % (2014–3558) 1/10 14.4
1/100 17.7
Sample vitamin B2 80 % (2014–3559) 1/10 14.3
1/100 17.6
NTC na N/A
na not applicable, N/A no amplification
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19 (described in [Genbank: JYFL01000000], and
containing the B. subtilis riboflavin biosynthesis genes
(“GM-cassette”) and the non-naturally present sequences
(vector) as input target sequence. Subsequently, the se-
lectivity of the designed primer pairs were in silico
tested. This test was performed using the “wprimer-
search” software available on wEMBOSS Open Source
Software package [31–33]. This software mimics the
PCR amplification with the tested primers and using as
template the DNA sequences present in a collection of
bacterial DNA sequences of non-GM bacterial genomes
of 248 strains, representing 122 species belonging to 72
genera, retrieved from the NCBI public database [34].
Only primer pairs that did not yield an in silico amplicon
using the DNA sequences of this collection of non-GM
bacteria strains were retained for the following steps. As a
last verification step, a megablast of the amplicon was per-
formed to verify that no similar sequence exists [35–37].
VitB2-UGM qPCR assay
All qPCR assays were performed on an Applied Biosys-
tems 7300 Real-Time PCR System (Applied Biosystems,
Life Technologies, Gent, Belgium) using MicroAmp®
Optical 96-Well Reaction Plates closed with MicroAmp®
Optical 8-Cap Strips (Applied Biosystems, Life Tech-
nologies, Gent, Belgium). The reaction was performed in
a final volume of 25 μl containing 5 μl of the appropriate
template (104 copies of gDNA of each of the tested
strains (Table 2) for the specificity test or a serial dilu-
tion of gDNA of GM-B. subtilis strain 2014–3557 over-
producing riboflavin [21] for the sensitivity test), 1X
TaqMan® PCR Mastermix (Diagenode, Liège, Belgium),
250 nM of each primer and 100nM of the probe (Table 1,
i.e. VitB2-UGM qPCR assay). The estimated bacterial
genomic copy number was calculated according to the
genome size of each targeted bacteria (information avail-
able in the NCBI database; for Bacillus strains, the previ-
ously reported genome size of B. subtilis of 4, 214, 810 bp
was used) using the formula previously presented [38].
The following thermal program was applied: A single
cycle of DNA polymerase activation for 10 min at 95 °C
followed by 45 amplification cycles of 15 sec at 95 °C
(denaturing step) and 1 min at 60 °C (annealing-extension
step). The fluorescent reporter signal was normalized
against the internal reference dye (ROX) signal and the
threshold limit setting was performed in automatic mode,
according to the ABI Sequence Detection Software ver-
sion 1.4 (Applied Biosystems, Life Technologies, Gent,
Belgium), unless manual adjustment was considered ne-
cessary. “No Template” Controls (NTC) using DNase and
RNase free water (Acros, Geel, Belgium) and DNA diluent
control using calf thymus DNA (CTD, Invitrogen) at 4
ng/μl were included in each assay to assess respectively
primer dimer formation and non-specific amplification.
Sanger sequencing on a ABI3130xl Genetic Analyzer (Life
Technologies, Gent, Belgium) according to the manufac-
turer’s instructions, was used to confirm the obtained
amplicon.
The qPCR assay gives one result, i.e. the quantification
cycle (Cq) value which represents the fractional cycle at
which the PCR amplification reaches the threshold level
for the reaction [39].
Dynamic range and calculation of the PCR efficiency
The dynamic range was assessed for the VitB2-UGM
qPCR assay by the analysis in duplicate of a serial dilu-
tion in a carrier DNA background (4 ng/μL Calf Thymus
DNA (CTD) (Invitrogen, Life Technologies, Gent,
Belgium)) of gDNA (10,000 to 0.01 theoretical genomic
copies) of the GM-Bacillus subtilis strain 2014–3557
overproducing riboflavin [21]. The carrier DNA avoids
the improper dilution due to low concentration of
gDNA. The PCR efficiency was calculated according to
the formula previously reported [40].
Sensitivity test and repeatability calculation
The GM-B. subtilis strain 2014–3557 overproducing ribo-
flavin [21] was used as target. To determine the LOD, a
range between 10 and 0.1 theoretical genomic copies was
tested (i.e. 10, 5, 2, 1 and 0.1). Each dilution was tested in
six replicates. Moreover, the analysis was performed three
times independently, under repeatable conditions, result-
ing in 18 repeats for each dilution point. In order to verify
that the DNA concentration used to calculate the LOD
was not overestimated, the number of positive signals was
recorded over the 18 replicates. The “0.1 copy” was in-
cluded to verify that the concentration of DNA used to
calculate the LOD was approximately correct.
The repeatability of the assay can be evaluated thanks to
the independent tests performed, i.e. with the same proto-
col, with the same samples, by the same operator using
the same apparatus within a short interval of time [41].
The repeatability limit (r) and the relative standard devi-
ation of repeatability (RSDr) were calculated according to
ISO 16140 [42]. The RSDr and r-values of the Cq-values
were calculated at each dilution point.
Extraction of genomic DNA from vitamin B2 samples
Genomic DNA (gDNA) was extracted from feed additive
samples using a CTAB-based method adapted from
Dellaporta et al. [43]. Four volumes of CTAB extraction
buffer (NaCl 1.4 M, EDTA 0.02 M, Tris–HCl 0.1 M,
CTAB 2 %), supplemented with Ribonuclase A (at a final
concentration of 0.1 mg/ml) were added to 250 mg of
vitamin B2 powder, mixed regularly and incubated for 30
min at 65 °C. Next, Proteinase K (at a final concentration
of 0.4 mg/ml) was added, mixed regularly and incubated
for 30 min at 65 °C. After centrifugation (10 min at 12,000
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g), the supernatant was collected and 1 volume of chloro-
form was added and vortexed for 30 sec. After mixing and
centrifugation (15 min at 12,000 g), the upper phase was
collected. 0.6 volumes of isopropanol and 0.4 volumes of
ammonium acetate 10 M were added, gently mixed by in-
version, incubated for 30 min on ice and centrifuged (15
min at 12,000 g). The supernatant was discarded and
the pellet was washed with 1 ml of 70 % ethanol
and subsequently centrifuged (15 min at 12,000 g).
The pellet was dried for a few minutes at 37 °C. Fi-
nally, the pellet was re-suspended in 350 μl of TE (10 mM
Tris-0.2 mM EDTA pH 8.0) pre-warmed at 50 °C for 2
min. gDNA extracts were then stored at +4 °C. For the
qPCR analysis, 1/10 and 1/100 dilutions were made in TE
(10 mM Tris-0.2 mM EDTA pH 8.0) and analysed in du-
plicate with the VitB2-UGM qPCR assay as described
above.
Availability of supporting data
The data sets supporting the results of this article are in-
cluded within the article and its additional files:
Additional file 1: Figure S1: Sequence of B. subtilis
subsp. subtilis str. 168 genome [Genbank:CP010052.1]
corresponding to the region containing part of Con-
tig00019 and Contig00022, and the “37 bp gap”.
Additional file 2: Figure S2: Alignment of sequences of
PCR fragment containing the “37 bp gap” between Con-
tig00019 and Contig00022 and the B. subtilis subsp. sub-
tilis str. 168 genome sequence [Genbank:CP010052.1].
Additional files
Additional file 1: Figure S1. Sequence of B. subtilis subsp. subtilis str.
168 genome sequence [Genbank:CP010052.1] corresponding to the
region containing part of Contig00019 and Contig00022. There is a gap
of 37 basepairs (uncoloured region in the figure) between Contig00019
(pink region in figure) and Contig00022 (yellow region in figure), when
aligning the obtained contigs to B. subtilis subsp. subtilis str. 168 genome
sequence [Genbank:CP010052.1]. PCR and sequence analysis were used
to confirm that the genomic regions present on both contigs are indeed
adjacent in the GM-Bacillus genome. Hereto, primers Scaf-19-F3-seq
(positioned on Contig00019, indicated in green) and Scaf-22-R-seq
(positioned on Contig00022, indicated in blue) were used to amplify the
flanking regions of the junction between Contig00019 and Contig00022.
Subsequently, the obtained PCR fragment was sequenced. (PDF 101 kb)
Additional file 2: Figure S2. Alignment of sequences of PCR fragment
containing the “37 bp gap” between Contig00019 and Contig00022 and
the B. subtilis subsp. subtilis str. 168 genome sequence
[Genbank:CP010052.1]. Alignment of the obtained sequences (“57-scaf19-
F3” and “57-scaf22-R”) of the PCR fragment containing the junction
between Contig00019 and Contig00022 to the corresponding region in
the B. subtilis subsp. subtilis str. 168 genome sequence
[Genbank:CP010052.1] (region taken as displayed in Additional file 1:
Figure S1). The nucleotides at the beginning of the obtained sequence
are to be ignored, as these are of lower quality, which is known for
Sanger sequencing with BigDye Terminator v3.1. The position
corresponding to the “37 bp gap” has been indicated with a red box. It is
clear that both contigs are adjacent in the GM-Bacillus genome, and that
the sequence region corresponding to the “gap” was not present in the
reads/contigs obtained through the the NGS analysis. (PDF 534 kb)
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